Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared Genetic Characteristics of Coronary Artery Disease and Peripheral artery Disease: Insights From Integrated Bioinformatics Analysis of RNA-Sequencing Data. | Bioinform Biol Insights | 2025 | 40535026 | PubTator, text mining | PubMed |
| Complexity of metabolic dysfunction-associated steatotic liver disease: State of the art review. | J Chin Med Assoc | 2025 | 40506815 | PubTator, text mining | PubMed |
| Immunopathogenic mechanisms and immunoregulatory therapies in MASLD. | Cell Mol Immunol | 2025 | 40494889 | PubTator, text mining | PubMed |
| Analysis of immune status and prognostic model incorporating lactate metabolism and immune-related genes in clear cell renal cell carcinoma. | Discov Oncol | 2025 | 40481935 | PubTator, text mining | PubMed |
| Occupational Exposure to Pesticides Among Farmworkers in Morocco: A Study Framework for Endocrine and Epigenetic Effect Assessment. | Toxics | 2025 | 40423419 | PubTator, text mining | PubMed |
| Disease-associated SNP variants of THRβ: Insights into the molecular determinants of aberrant receptor function. | Mol Cell Endocrinol | 2025 | 40419015 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells. | Front Pharmacol | 2025 | 40371351 | PubTator, text mining | PubMed |
| Intercepting Modes of Cellular Communication. | Cell Mol Gastroenterol Hepatol | 2025 | 40348018 | PubTator, text mining | PubMed |
| Thyroid dysfunction in MASLD: Results of a nationwide study. | JHEP Rep | 2025 | 40342634 | PubTator, text mining | PubMed |
| Identification of new families and variants in autosomal dominant macular dystrophy associated with THRB. | Sci Rep | 2025 | 40295579 | PubTator, text mining | PubMed |
| Multiomic insight into the involvement of cell aging related genes in the pathogenesis of endometriosis. | Sci Rep | 2025 | 40269081 | PubTator, text mining | PubMed |
| Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies. | Int J Mol Sci | 2025 | 40243565 | PubTator, text mining | PubMed |
| Late-Onset Thyroid Hormone Resistance Following Total Thyroidectomy for Papillary Thyroid Cancer. | Cureus | 2025 | 40236334 | PubTator, text mining | PubMed |
| Resmetirom: The First Disease-Specific Treatment for MASH. | Int J Endocrinol | 2025 | 40212963 | PubTator, text mining | PubMed |
| Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom. | Curr Issues Mol Biol | 2025 | 40136408 | PubTator, text mining | PubMed |
| Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis. | Expert Opin Pharmacother | 2025 | 40100944 | PubTator, text mining | PubMed |
| Unlocking the potential of THR-β agonist therapies: resmetirom's chemistry, biology, and patent insights. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40067441 | PubTator, text mining | PubMed |
| Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications. | Acta Pharm Sin B | 2025 | 40041922 | PubTator, text mining | PubMed |
| Graves' Masquerade: A Case of Resistance to Thyroid Hormone (RTH) Syndrome. | Cureus | 2025 | 40027009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=11